Amwill Health Care Ltd Stock Price Today (NSE: AMWILL)
Fundamental Score
Amwill Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amwill Health Care Ltd share price today is ₹42.50, up +0.00% on NSE/BSE as of 17 September 2026. Amwill Health Care Ltd (AMWILL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹85.02 (Cr). The 52-week high for AMWILL share price is ₹62.99 and the 52-week low is ₹28.91. At a P/E ratio of 7.18x, AMWILL is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 15.25% and a debt-to-equity ratio of N/A.
Amwill Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Amwill Health Care Ltd share price chart: 3.37% return over the past month. 52-week high ₹62.99, 52-week low ₹28.91.
Amwill Health Care Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹43.50 | ₹43.50 | ₹42.24 | ₹42.50 | 6.00K (Cr) | |
| ₹44.00 | ₹44.00 | ₹44.00 | ₹44.00 | 1.20K (Cr) | |
| ₹41.50 | ₹43.15 | ₹41.50 | ₹43.00 | 6.00K (Cr) | |
| ₹43.51 | ₹43.51 | ₹42.50 | ₹42.90 | 7.20K (Cr) | |
| ₹42.75 | ₹43.51 | ₹42.71 | ₹43.51 | 4.80K (Cr) | |
| ₹41.75 | ₹44.50 | ₹41.75 | ₹42.50 | 13.20K (Cr) | |
| ₹43.50 | ₹43.50 | ₹43.00 | ₹43.00 | 9.60K (Cr) | |
| ₹43.50 | ₹44.00 | ₹43.00 | ₹43.00 | 7.20K (Cr) | |
| ₹43.70 | ₹44.00 | ₹43.50 | ₹43.50 | 6.00K (Cr) | |
| ₹43.50 | ₹43.50 | ₹43.50 | ₹43.50 | 0.00 (Cr) |
Amwill Health Care Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹43.70 | ₹44.50 | ₹41.50 | ₹42.50 | -2.75% | |
| ₹41.50 | ₹45.00 | ₹39.60 | ₹43.50 | +4.82% | |
| ₹43.00 | ₹45.60 | ₹38.60 | ₹42.50 | -1.16% | |
| ₹34.33 | ₹49.75 | ₹34.33 | ₹44.00 | +28.17% | |
| ₹35.48 | ₹36.40 | ₹30.69 | ₹32.70 | -7.84% | |
| ₹29.50 | ₹38.50 | ₹28.91 | ₹34.89 | +18.27% | |
| ₹33.15 | ₹36.98 | ₹28.95 | ₹28.95 | -12.67% | |
| ₹35.96 | ₹37.79 | ₹34.50 | ₹34.85 | -3.09% | |
| ₹48.90 | ₹50.90 | ₹36.25 | ₹39.55 | -19.12% | |
| ₹42.05 | ₹47.94 | ₹34.00 | ₹47.63 | +13.27% | |
| ₹56.00 | ₹57.00 | ₹40.00 | ₹42.05 | -24.91% | |
| ₹53.30 | ₹55.96 | ₹50.00 | ₹54.00 | +1.31% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amwill Health Care Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amwill Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMWILL across key market metrics for learning purposes.
Positive Indicators
12 factors identified
Strong Return on Equity (15.25%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (16.70%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (27.55%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 7.18 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (79.33%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (39.36%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (21.43% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (15.07% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (68.09% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Healthy Liquidity Position (Current Ratio: 11.11)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (70.65%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amwill Health Care Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Amwill Health Care Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amwill Health Care LtdAmwill Health C...Selected✓ AMWILL • 544353 | 78/100 | ₹42.50₹43 | ₹85.02₹85.02 | 7.18Average 7.2 Average | 15.25%Good 15.25% Good | 16.70%Good 16.70% Good | — — | 68.09%Excellent 68.09% Excellent | 21.43%Excellent 21.43% Excellent | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1851.80₹1852 | ₹444302.37₹444302.37 | 36.74Average 36.7 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9421.00₹9421 | ₹249656.50₹249656.50 | 85.48Average 85.5 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4948.00₹4948 | ₹167470.01₹167470.01 | 79.04Average 79.0 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1124.20₹1124 | ₹112195.16₹112195.16 | 25.05Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1372.20₹1372 | ₹110853.17₹110853.17 | 32.87Average 32.9 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1941.00₹1941 | ₹104862.52₹104862.52 | 95.80Average 95.8 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1670.20₹1670 | ₹96103.31₹96103.31 | 26.10Average 26.1 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1136.80₹1137 | ₹94922.80₹94922.80 | 29.38Average 29.4 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2071.50₹2072 | ₹94719.34₹94719.34 | 17.12Average 17.1 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2259.00₹2259 | ₹93296.70₹93296.70 | 45.65Average 45.6 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price444302.37 Cr
- Divi's Laboratories Limited share price249656.50 Cr
- Torrent Pharmaceuticals Limited share price167470.01 Cr
- Zydus Lifesciences Limited share price112195.16 Cr
- Cipla Limited share price110853.17 Cr
Amwill Health Care Ltd Quarterly Performance
Latest quarterly metrics for AMWILL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
39.36%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
79.33%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.43%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
68.09%
Compounded annual net profit growth over 5 years
Amwill Health Care Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMWILL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amwill Health Care Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amwill Health Care Ltd (AMWILL) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Amwill Health Care Ltd
About AMWILL (Amwill Health Care Ltd)
Amwill Health Care Ltd is a pharmaceutical enterprise dedicated to innovating and delivering advanced healthcare solutions. With a strong commitment to research and development, AM...WILL focuses on creating novel therapeutic interventions and improving existing treatment modalities across various medical disciplines. The company is structured around a multifaceted approach, encompassing the entire lifecycle of pharmaceutical products, from initial discovery and preclinical studies to clinical trials, regulatory approvals, manufacturing, and commercialization. AMWILL's core strength lies in its team of experienced scientists, clinicians, and industry professionals who collaborate to address unmet medical needs and enhance patient outcomes. Through strategic partnerships and a continuous pursuit of scientific excellence, AMWILL strives to be a catalyst for progress in the ever-evolving landscape of healthcare. AMWILL Health Care Ltd distinguishes itself through its state-of-the-art manufacturing facilities and rigorous quality control processes, ensuring that its products consistently meet the highest standards of safety and efficacy. The company's diverse portfolio includes a wide array of pharmaceutical formulations, catering to a broad spectrum of therapeutic areas, including but not limited to, cardiovascular health, oncology, neurology, and infectious diseases. By embracing cutting-edge technologies and adhering to stringent regulatory guidelines, AMWILL ensures that its offerings are not only effective but also accessible to patients worldwide. The company actively invests in building a robust distribution network and fostering strong relationships with healthcare providers, aiming to facilitate the seamless delivery of its products to those who need them most. Amwill Health Care Ltd is dedicated to corporate social responsibility, understanding that its role extends beyond providing medicines to fostering a healthier and more sustainable future. Through various initiatives, AMWILL actively supports community health programs, promotes environmental conservation, and upholds ethical business practices. The company is committed to transparency and accountability in all its operations, striving to earn the trust and respect of its stakeholders. By prioritizing innovation, quality, and social impact, AMWILL aims to be a trusted partner in healthcare, contributing to the well-being of individuals and communities around the globe. Its overarching goal is to transform lives through its commitment to pharmaceutical excellence and responsible corporate citizenship.
Company Details
Key Leadership
AMWILL Share Price: Frequently Asked Questions
What is the current share price of Amwill Health Care Ltd?
Amwill Health Care Ltd (AMWILL) trades at ₹42.50 on NSE and BSE. Market cap ₹85.02 (Cr). Educational data only.
What is the P/E ratio of Amwill Health Care Ltd?
Amwill Health Care Ltd has a P/E of 7.18x vs industry average 34.89x.
What is the Bull Run score for Amwill Health Care Ltd?
Amwill Health Care Ltd has a Bull Run score of 78/100 based on 25+ financial parameters.
Does Amwill Health Care Ltd pay dividends?
Amwill Health Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amwill Health Care Ltd?
Amwill Health Care Ltd has ROE of 15.25%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amwill Health Care Ltd?
Amwill Health Care Ltd has debt-to-equity of N/A.
Is Amwill Health Care Ltd a good investment?
Bull Run gives Amwill Health Care Ltd a score of 78/100. This is not investment advice — consult a SEBI-registered advisor.